SCHEMBL4193440

SCHEMBL4193440

CC(C)(C)OC(=O)N(N)C(=O)NCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA7 P43166 1/20 0.47
CA14 Q9ULX7 1/20 0.47
RIPK1 Q13546 1/20 0.47
ATM Q13315 1/20 0.46
LMNA P02545 1/20 0.44
RAB9A P51151 1/20 0.44
CTSK P43235 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
OPRM1 P35372 1/20 0.43
OPRL1 P41146 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
PPID Q08752 1/20 0.43
MMP8 P22894 1/20 0.43
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4246502 0.82 CA12 (0.46) CA12CA1CA7CA14RIPK1
SCHEMBL13430486 0.78 OPRM1 (0.44) CA12CA1CA7CA14RIPK1
SCHEMBL3838871 0.77 CA12 (0.63) CA12CA1CA7CA14RIPK1
SCHEMBL6648512 0.77 ALDH1A1 (0.49) LMNASMN1; SMN2HPGDAKT1
SCHEMBL31248355 0.76 PRSS1 (0.52) CA12CA1CA7CA14RIPK1
SCHEMBL4254554 0.76 PPID (0.48) CA12CA1CA7CA14RIPK1
SCHEMBL4246507 0.76 AKT1 (0.53) CA12CA1CA7CA14RIPK1
SCHEMBL4401029 0.76 LMNA (0.48) CA12CA1CA7CA14ATM
SCHEMBL5821792 0.76 SMN1; SMN2 (0.42) CA12CA1CA7CA14RIPK1
SCHEMBL3229771 0.75 OPRM1 (0.55) RIPK1RAB9ASMN1; SMN2OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed
EP-2029142-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION Choongwae Pharma Corporation (KR) 2009-03-04 EP disclosed
WO-2007139346-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION MYLK2, TNNC1, MYH2 CA12 3213/4885CA1 2239/4885CA7 3819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.